Gene-Tailored therapy aims to outsmart breast cancer
NCT ID NCT02624973
First seen Feb 16, 2026 · Last updated May 20, 2026 · Updated 7 times
Summary
This study tests a personalized approach to treat high-risk breast cancer before surgery. Researchers use genetic testing of the tumor to choose the best drugs for each patient. The goal is to improve response and understand why some tumors resist treatment. About 200 adults with large or aggressive breast tumors are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus University Hospital
Lørenskog, Akershus, Norway
-
Haukeland University Hospital
Bergen, Hordaland, 5021, Norway
-
Helse Fonna
Haugesund, Rogaland, Norway
-
Helse Førde
Førde, Sogn Og Fjordande, Norway
-
Helse Nord/UNN
Tromsø, Troms, Norway
-
Helse Stavanger
Stavanger, Rogaland, Norway
-
St. Olavs Hospital
Trondheim, Sør Trøndelag, Norway
Conditions
Explore the condition pages connected to this study.